Tags : Respiratory Therapies

Novartis to Collaborate with Glenmark to Promote, Commercialize and Distribute

Shots: Novartis signs an exclusive commercialization agreement with Glenmark to commercialize three respiratory therapies i.e, Seebri, Onbrize and Ultibro for treating COPD in Brazil. Novartis will be responsible for the manufacturing of therapies The focus of the collaboration is to bolster Glenmark’s respiratory franchise and to expand its respiratory portfolio in Brazil. The agreement will […]Read More